1. Home
  2. APLS vs PII Comparison

APLS vs PII Comparison

Compare APLS & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • PII
  • Stock Information
  • Founded
  • APLS 2009
  • PII 1954
  • Country
  • APLS United States
  • PII United States
  • Employees
  • APLS N/A
  • PII N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • PII Recreational Games/Products/Toys
  • Sector
  • APLS Health Care
  • PII Consumer Discretionary
  • Exchange
  • APLS Nasdaq
  • PII Nasdaq
  • Market Cap
  • APLS 3.6B
  • PII 3.8B
  • IPO Year
  • APLS 2017
  • PII 1987
  • Fundamental
  • Price
  • APLS $27.52
  • PII $46.54
  • Analyst Decision
  • APLS Buy
  • PII Hold
  • Analyst Count
  • APLS 18
  • PII 13
  • Target Price
  • APLS $46.71
  • PII $62.45
  • AVG Volume (30 Days)
  • APLS 1.4M
  • PII 2.0M
  • Earning Date
  • APLS 02-28-2025
  • PII 01-28-2025
  • Dividend Yield
  • APLS N/A
  • PII 5.76%
  • EPS Growth
  • APLS N/A
  • PII N/A
  • EPS
  • APLS N/A
  • PII 1.95
  • Revenue
  • APLS $715,216,000.00
  • PII $7,273,000,000.00
  • Revenue This Year
  • APLS $97.25
  • PII N/A
  • Revenue Next Year
  • APLS $12.68
  • PII $5.05
  • P/E Ratio
  • APLS N/A
  • PII $23.87
  • Revenue Growth
  • APLS 162.10
  • PII N/A
  • 52 Week Low
  • APLS $24.34
  • PII $42.85
  • 52 Week High
  • APLS $71.90
  • PII $100.91
  • Technical
  • Relative Strength Index (RSI)
  • APLS 38.99
  • PII 40.39
  • Support Level
  • APLS $26.84
  • PII $42.85
  • Resistance Level
  • APLS $28.59
  • PII $47.30
  • Average True Range (ATR)
  • APLS 1.12
  • PII 1.71
  • MACD
  • APLS -0.03
  • PII 0.57
  • Stochastic Oscillator
  • APLS 18.09
  • PII 82.98

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products retailed through more than 2,500 dealers in North America and through 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

Share on Social Networks: